Parenteral vs. oral sumatriptan and naratriptan: Plasma levels and efficacy in migraine. A comment

30Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The clinical efficacy in migraine was compared for oral and subcutaneous sumatriptan and naratriptan. Doses of the two administration forms were chosen as resulting in comparable blood concentrations. Subcutaneous administrations of the drugs were superior for efficacy than the oral forms. This most likely due to a quicker rise in blood concentrations after subcutaneous injections. In designing new therapies for migraine one should aim at a quick absorption of the drug, which will probably result in an increased efficacy. © Springer-Verlag Italia 2007.

Cite

CITATION STYLE

APA

Tfelt-Hansen, P. (2007, October). Parenteral vs. oral sumatriptan and naratriptan: Plasma levels and efficacy in migraine. A comment. Journal of Headache and Pain. https://doi.org/10.1007/s10194-007-0411-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free